Chymotrypsin (Shanghai No 1 Biochemical & Pharmaceutical)

注射用糜蛋白酶（上海上药第一生化药业有限公司）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChymotrypsin (Shanghai No 1 Biochemical & Pharmaceutical)
Drug Alias Namechymotrypsin (intramuscular)
ClassificationBiologics > Protein drugs > Enzyme > Non-recombinant enzyme
Mechanisms of ActionProtease modulators
TargetsProtease
Therapy Area/IndicationsWounds and InjuriesUlcerInflammation +[7] 
Global Approved IndicationsWounds and InjuriesUlcerInflammation +[7] 
Approved Indications in ChinaWounds and InjuriesUlcerInflammation +[7] 
Original Approved Country/TerritoryMainland China
Original Approved Date1995/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Pharmaceuticals Holding Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Pharmaceuticals Holding Co Ltd
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesUlcerInflammation +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeB06AA04S01KX01
Related LinksN/A